ORYL Photonics Closes its Series A Round - BioAlps
Summary
ORYL Photonics closed its Series A funding round in July 2025, backed by existing shareholders. The company will use the capital to commercialize its ORYL F1 laboratory instrument and expand its solubility measurement service offering. ORYL F1 uses proprietary laser-based light-scattering technology to measure drug solubility and aggregation for pharmaceutical, biotech, and life science research. The company says the funding will help it scale operations after launching the product in May 2025.
Funding
Amount
None
Total raised
Date
July 1, 2025
Announcement date
Investors
-
Lead investors
Company
orylphotonics.com
Funded company
Classifications
industries
Pharmaceuticals and Chemical
applications
Calendar, Scheduling
AskAI Classifications
Labels
SaaS
Scientific Software
Laboratory Informatics
Linked Companies
ORYL Photonics
up to $1M